{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:43:00Z","timestamp":1769550180939,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.annder.2013.01.428","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T12:34:14Z","timestamp":1361882054000},"page":"363-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pyoderma gangrenosum avec localisations pulmonaires trait\u00e9 par infliximab"],"prefix":"10.1016","volume":"140","author":[{"given":"D.","family":"Deregnaucourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Buche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Coopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Basraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Turck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2013.01.428_bib0005","first-page":"290","article-title":"Contribution \u00e0 l\u2019\u00e9tude du phad\u00e9g\u00e9nisme g\u00e9om\u00e9trique","volume":"25","author":"Brocq","year":"1908","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"10.1016\/j.annder.2013.01.428_bib0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","article-title":"Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults","volume":"22","author":"Brunsting","year":"1930","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.annder.2013.01.428_bib0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","article-title":"From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research","volume":"55","author":"Wallach","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0020","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0025","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103\u00a0patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0030","first-page":"185","article-title":"Cutaneous manifestations of ulcerative colitis","volume":"15","author":"Areias","year":"1987","journal-title":"Med Cutan Ibero Lat Am"},{"issue":"Suppl. 4","key":"10.1016\/j.annder.2013.01.428_bib0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2004.02055.x","article-title":"Review article: skin complications associated with inflammatory bowel disease","volume":"20","author":"Tavarela Veloso","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annder.2013.01.428_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annder.2013.01.428_bib0045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2013.01.428_bib0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.annder.2013.01.428_bib0055","first-page":"65","article-title":"Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report","volume":"152","author":"Delbrel","year":"2001","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.annder.2013.01.428_bib0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2133.1999.03055.x","article-title":"Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia","volume":"141","author":"Vadillo","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.clindermatol.2005.01.014","article-title":"Pyoderma gangrenosum: uncommon presentations","volume":"23","author":"Ahmadi","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2230.2008.02756.x","article-title":"Pyoderma gangrenosum manifesting as a cavitating lung lesion","volume":"33","author":"Field","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0075","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.lpm.2007.03.031","article-title":"Manifestations pulmonaires du pyoderma gangrenosum","volume":"36","author":"Chahine","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.annder.2013.01.428_bib0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1067\/mjd.2000.103627","article-title":"Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis","volume":"43","author":"Brown","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"5\u00a0Suppl.","key":"10.1016\/j.annder.2013.01.428_bib0085","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.jaad.2008.06.017","article-title":"Primary pyoderma gangrenosum of the lungs","volume":"59","author":"Kitagawa","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0095","first-page":"930","article-title":"Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody","volume":"137","author":"Tan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1346-8138.2011.01346.x","article-title":"Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease","volume":"39","author":"Hayashi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0105","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annder.2013.01.428_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.2008.00825.x","article-title":"Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab","volume":"26","author":"Rajan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archdermatol.2011.168","article-title":"Interleukin 23\u00a0expression in pyoderma gangrenosum and targeted therapy with ustekinumab","volume":"147","author":"Guenova","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2013.01.428_bib0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo-controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963813004535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963813004535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:00:26Z","timestamp":1758970826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963813004535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0151963813004535"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2013.01.428","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyoderma gangrenosum avec localisations pulmonaires trait\u00e9 par infliximab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2013.01.428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}